304 related articles for article (PubMed ID: 12025249)
1. [Erroneous attitudes in the use of neuromuscular blocking agents].
Ortiz-Gómez JR
Rev Esp Anestesiol Reanim; 2002 Feb; 49(2):65-8. PubMed ID: 12025249
[No Abstract] [Full Text] [Related]
2. A survey of current management of neuromuscular block in the United States and Europe.
Naguib M; Kopman AF; Lien CA; Hunter JM; Lopez A; Brull SJ
Anesth Analg; 2010 Jul; 111(1):110-9. PubMed ID: 19910616
[TBL] [Abstract][Full Text] [Related]
3. A novel approach to reversal of neuromuscular blockade.
Della Rocca G; Pompei L
Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
[TBL] [Abstract][Full Text] [Related]
4. Reversal of neuromuscular blocking agents: current practice.
Nagelhout JJ
AANA J; 2013 Dec; Suppl():8-11. PubMed ID: 24592527
[No Abstract] [Full Text] [Related]
5. Residual paralysis after emergence from anesthesia.
Plaud B; Debaene B; Donati F; Marty J
Anesthesiology; 2010 Apr; 112(4):1013-22. PubMed ID: 20234315
[No Abstract] [Full Text] [Related]
6. Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent?
Lien CA
Anesthesiology; 2010 Jan; 112(1):16-8. PubMed ID: 19952723
[No Abstract] [Full Text] [Related]
7. Knowledge of residual curarization: an Italian survey.
Di Marco P; Della Rocca G; Iannuccelli F; Pompei L; Reale C; Pietropaoli P
Acta Anaesthesiol Scand; 2010 Mar; 54(3):307-12. PubMed ID: 19839947
[TBL] [Abstract][Full Text] [Related]
8. Sugammadex in anesthesia practice.
Duvaldestin P; Plaud B
Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
[TBL] [Abstract][Full Text] [Related]
9. [Monitoring of neuromuscular block and prevention of residual paralysis].
Fuchs-Buder T; Meistelman C
Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S46-50. PubMed ID: 19887277
[TBL] [Abstract][Full Text] [Related]
10. Neuromuscular monitoring: old issues, new controversies.
Kopman AF
J Crit Care; 2009 Mar; 24(1):11-20. PubMed ID: 19272534
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
Lee C; Katz RL
J Crit Care; 2009 Mar; 24(1):43-9. PubMed ID: 19272538
[TBL] [Abstract][Full Text] [Related]
12. Have we learned how to relax our patients, by thinking outside the box?
Lee C; Katz RL
J Crit Care; 2009 Mar; 24(1):1-4. PubMed ID: 19272532
[No Abstract] [Full Text] [Related]
13. Clinical limitations of acetylcholinesterase antagonists.
Caldwell JE
J Crit Care; 2009 Mar; 24(1):21-8. PubMed ID: 19272535
[TBL] [Abstract][Full Text] [Related]
14. Intermediate-Acting Nondepolarizing Neuromuscular Blocking Agents and Risk of Postoperative 30-Day Morbidity and Mortality, and Long-term Survival.
Bronsert MR; Henderson WG; Monk TG; Richman JS; Nguyen JD; Sum-Ping JT; Mangione MP; Higley B; Hammermeister KE
Anesth Analg; 2017 May; 124(5):1476-1483. PubMed ID: 28244947
[TBL] [Abstract][Full Text] [Related]
15. Coronary vasospasm during the reversal of neuromuscular block using neostigmine.
Kido K; Mizuta K; Mizuta F; Yasuda M; Igari T; Takahashi M
Acta Anaesthesiol Scand; 2005 Oct; 49(9):1395-6. PubMed ID: 16146484
[No Abstract] [Full Text] [Related]
16. Residual neuromuscular blockade in myotonic dystrophy: lessons unlearned and sugammadex.
Stewart PA; Phillips S; de Boer HD
Anaesth Intensive Care; 2011 Jul; 39(4):756-7; author reply 757. PubMed ID: 21823393
[No Abstract] [Full Text] [Related]
17. "Neostigmine-resistant curarization".
Baraka A
Middle East J Anaesthesiol; 2013 Jun; 22(2):131-4. PubMed ID: 24180159
[No Abstract] [Full Text] [Related]
18. Prolonged neuromuscular block associated to non-alcoholic steatohepatitis in morbidly obese patient: neostigmine versus sugammadex.
Carron M; Parotto E; Ori C
Minerva Anestesiol; 2012 Jan; 78(1):112-3. PubMed ID: 22237790
[No Abstract] [Full Text] [Related]
19. Case-Based Management of Neuromuscular Block, Reversal, and Recovery: Ensuring Optimal Outcomes.
AANA J; 2015 Dec; Suppl():4-15. PubMed ID: 26749974
[No Abstract] [Full Text] [Related]
20. Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine.
Miller RD; Ward TA
Anesth Analg; 2010 Jul; 111(1):3-5. PubMed ID: 20576958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
